NCT07082426View on ClinicalTrials.gov

Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

March 13, 2026

Study Completion Date

May 30, 2026

Conditions
Symptomatic Severe Aortic Stenosis
Interventions
DEVICE

Balloon expandable TAVI

Prospective, single-arm, multi-center early experience study.

Trial Locations (3)

100107

Republican Centre of Emergency Medicine, Tashkent

0112

Israeli - Georgian Medical Research Clinic Healthycore, Tbilisi

0159

Tbilisi Heart and Vascular Clinic, Tbilisi

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY